PLCG2 and colorectal carcinoma: In terms of immune-related scores, CRC patients in the high PLCG2 expression group were found to have lower cytolytic score, inflammation score, StromalScore, InmuneScore, and ESTIMATEScore compared to those in the other group (Figure S8A).